Works matching DE "DEFERASIROX"

Results: 334

Effectiveness of Deferasirox in Pediatric Thalassemia Patients: Experience from a Tertiary Care Hospital of Odisha.

Published in:

Indian Journal of Pharmacology, 2020, v. 52, n. 3, p. 172, doi. 10.4103/ijp.IJP_68_18

By:

Panigrahi, Mousumee;
Swain, Trupti Rekha;
Jena, Rabindra Kumar;
Panigrahi, Ashutosh;
Debta, Nishant

Publication type:

Article

Perforated duodenal ulcer: A rare complication of deferasirox in children.

Published in:

Indian Journal of Pharmacology, 2013, v. 45, n. 3, p. 293, doi. 10.4103/0253-7613.111901

By:

Yadav, Sunil Kumar;
Gupta, Vipul;
Kohly, Ashraf El;
Fadhli, Wasmi Al

Publication type:

Article

Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients.

Published in:

Journal of Pharmacy & Pharmacology, 2017, v. 69, n. 5, p. 525, doi. 10.1111/jphp.12559

By:

Allegra, Sarah;
Cusato, Jessica;
De Francia, Silvia;
Pirro, Elisa;
Massano, Davide;
Piga, Antonio;
D'Avolio, Antonio

Publication type:

Article

Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment.

Published in:

Journal of Pharmacy & Pharmacology, 2016, v. 68, n. 11, p. 1417, doi. 10.1111/jphp.12638

By:

Allegra, Sarah;
De Francia, Silvia;
Cusato, Jessica;
Pirro, Elisa;
Massano, Davide;
Piga, Antonio;
D'Avolio, Antonio

Publication type:

Article

Characterisation of a novel oral iron chelator: 1-( N- Acetyl-6- Aminohexyl)-3- Hydroxy-2- Methylpyridin-4-one.

Published in:

Journal of Pharmacy & Pharmacology, 2015, v. 67, n. 5, p. 703, doi. 10.1111/jphp.12373

By:

Pangjit, Kanjana;
Banjerdpongchai, Ratana;
Phisalaphong, Chada;
Fucharoen, Suthat;
Xie, Yuan Yuan;
Lu, Zi Dong;
Hider, Robert C.;
Srichairatanakool, Somdet

Publication type:

Article

Formulation, Optimization and Evaluation of Solid Dispersion of Deferasirox Using Factorial Design.

Published in:

Journal of Drug Delivery & Therapeutics, 2024, v. 14, n. 5, p. 23, doi. 10.22270/jddt.v14i5.6526

By:

Talla Shruti;
Wadher Kamlesh;
Umekar Milind;
Lohiya R. T.

Publication type:

Article

A Comparative Study between Effect of Physical Activity and ADAM, Vs Iron Salts on Some Physical Traces of Underground Water.

Published in:

International Journal of Pharmaceutical Research & Allied Sciences, 2019, v. 8, n. 3, p. 37

By:

A. S., Nadir;
El Deen Mustafa M., Mohie;
Taher, Ahmed;
Hassanin, Soha Osama

Publication type:

Article

Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1069854

By:

Yampayon, Kittika;
Anantachoti, Puree;
Chongmelaxme, Bunchai;
Yodsurang, Varalee

Publication type:

Article

Changes in corticostriatal connectivity and striatal tissue iron associated with efficacy of clozapine for treatment‑resistant schizophrenia.

Published in:

Psychopharmacology, 2022, v. 239, n. 8, p. 2503, doi. 10.1007/s00213-022-06138-0

By:

Blazer, Annie;
Chengappa, K. N. Roy;
Foran, William;
Parr, Ashley C.;
Kahn, Charles E.;
Luna, Beatriz;
Sarpal, Deepak K.

Publication type:

Article

The synthesis and antibacterial activity evaluation of oxazolidinone - deferasirox conjugates.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2022, v. 31, n. 12, p. 946, doi. 10.5246/jcps.2022.12.080

By:

Xintong Zhao;
Yuhua Hu;
Tong Qin;
Tianlei Li;
Wenxuan Zhang;
Song Wu

Publication type:

Article

Determination of deferasirox particle size distribution via laser diflraction and its application in establishing a correlation between particle size and drug dissolution in vitro.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 11, p. 912, doi. 10.5246/jcps.2021.11.079

By:

Yuyuan Chen;
Song Wu;
Liqing Chen;
Yuanyuan Zhang;
Zhonggao Gao;
Tianlei Li;
Wei Huang;
Qingyun Yang

Publication type:

Article

Health-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results fromthe EPIC Clinical Trial.

Published in:

Anemia (20901267), 2012, p. 1, doi. 10.1155/2012/297641

By:

Porter, John;
Bowden, Donald K.;
Economou, Marina;
Troncy, Jacques;
Ganser, Arnold;
Habr, Dany;
Martin, Nicolas;
Gater, Adam;
Rofail, Diana;
Abetz-Webb, Linda;
Lau, Helen;
Cappellini, Maria Domenica

Publication type:

Article

Two risk factors for hypozincemia in diabetic β-thalassemia patients: Hepatitis C and deferasirox.

Published in:

PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0284267

By:

Darvishi-Khezri, Hadi;
Karami, Hossein;
Naderisorki, Mohammad;
Ghazaiean, Mobin;
Kosaryan, Mehrnoush;
Mosanejad-Galchali, Amir;
Aliasgharian, Aily;
Karami, Hasan

Publication type:

Article

Antioxidant Activity of Deferasirox and Its Metal Complexes in Model Systems of Oxidative Damage: Comparison with Deferiprone.

Published in:

Molecules, 2021, v. 26, n. 16, p. 5064, doi. 10.3390/molecules26165064

By:

Timoshnikov, Viktor A.;
Kichigina, Lilia A.;
Selyutina, Olga Yu.;
Polyakov, Nikolay E.;
Kontoghiorghes, George J.

Publication type:

Article

Siderophore–Antibiotic Conjugate Design: New Drugs for Bad Bugs?

Published in:

Molecules, 2019, v. 24, n. 18, p. 3314, doi. 10.3390/molecules24183314

By:

Negash, Kokob H.;
Norris, James K.S.;
Hodgkinson, James T.;
Riedl, Rainer

Publication type:

Article

Managing Iron Overload in Patients with Myelodysplastic Syndromes with Oral Deferasirox Therapy.

Published in:

Oncologist, 2009, v. 14, n. 5, p. 489, doi. 10.1634/theoncologist.2008-0154

By:

JABBOUR, ELIAS;
GARCIA-MANERO, GUILLERMO;
TAHER, ALI;
KANTARJIAN, HAGOP M.

Publication type:

Article

A Deferasirox Derivative That Acts as a Multifaceted Platform for the Detection and Quantification of Fe 3+.

Published in:

Chemosensors, 2021, v. 9, n. 4, p. 68, doi. 10.3390/chemosensors9040068

By:

Steinbrueck, Axel;
Sedgwick, Adam C.;
Hwang, Suh-Mi;
Sen, Sajal;
Zhao, Michael Y.;
Huang, Dan-Ying;
Knoll, Daniel M.;
Wang, Yu-Ying;
Sessler, Jonathan L.

Publication type:

Article

Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-91983-w

By:

Piolatto, Andrea;
Berchialla, Paola;
Allegra, Sarah;
De Francia, Silvia;
Ferrero, Giovanni Battista;
Piga, Antonio;
Longo, Filomena

Publication type:

Article

Clinical relevance of deferasirox trough levels in β‐thalassemia patients.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 2, p. 213, doi. 10.1111/1440-1681.12879

By:

Allegra, Sarah;
Massano, Davide;
De Francia, Silvia;
Longo, Filomena;
Piccione, Francesca;
Pirro, Elisa;
Cusato, Jessica;
D'Avolio, Antonio;
Piga, Antonio

Publication type:

Article

Iron-chelating agent, deferasirox, inhibits neutrophil activation and extracellular trap formation.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2016, v. 43, n. 10, p. 915, doi. 10.1111/1440-1681.12612

By:

Kono, Mari;
Saigo, Katsuyasu;
Yamamoto, Shiori;
Shirai, Kohei;
Iwamoto, Shuta;
Uematsu, Tomoko;
Takahashi, Takayuki;
Imoto, Shion;
Hashimoto, Makoto;
Minami, Yosuke;
Wada, Atsushi;
Takenokuchi, Mariko;
Kawano, Seiji

Publication type:

Article

Skin diseases in patients with β-thalassemia major.

Published in:

2009

By:

Dogramaci, Asena Cigdem;
Savas, Nazan;
Ozer, Burcin;
Duran, Nizami

Publication type:

Report

Effects of deferoxamine versus deferasirox on hematology and liver parameters in children with beta -thalassemia major: A cross -sectional study from a single center.

Published in:

Iranian Journal of Pediatric Hematology & Oncology, 2023, v. 13, n. 4, p. 251, doi. 10.18502/ijpho.v13i4.13771

By:

Al-Nimer, Marwan S.;
Hamasalih, Raz M.;
Ratha, Rawa

Publication type:

Article

Visual and Auditory Complications during Deferasirox Therapy in Beta-thalassemia.

Published in:

Iranian Journal of Pediatric Hematology & Oncology, 2022, v. 12, n. 4, p. 229, doi. 10.18502/ijpho.v12i4.10913

By:

Poosheshdoost, Parastoo;
Faraji, Niloofar;
Zeinali, Tahereh;
Baghersalimi, Adel;
Miremarati, Aye;
Darbandi, Bahram

Publication type:

Article

Comparison of Magnetic Resonance Imaging T2 Results in Beta- Thalassemia Patients Treated by Deferasirox or Combination of Deferoxamine and Deferiprone.

Published in:

Iranian Journal of Pediatric Hematology & Oncology, 2020, v. 10, n. 4, p. 241

By:

Mirbehbahani, Nargesbeigom;
Vaseghi, Ghazal;
Rashidbaghan, Azam;
Vakili, Mohammad Ali;
Jahazi, Azam

Publication type:

Article

Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literature.

Published in:

2020

By:

Cilloni, Daniela;
Andreani, Giacomo;
Dragani, Matteo;
De Gobbi, Marco;
Saglio, Giuseppe

Publication type:

Letter

The positive effect of deferasirox on erythropoiesis in a patient with a dual diagnosis of myelofibrosis and diffuse large B-cell lymphoma.

Published in:

2017

By:

Kostos, Louise;
Chai, Khai Li;
Tam, Constantine S.;
Bazargan, Ali

Publication type:

Case Study

Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 11, p. 2752, doi. 10.1080/10428194.2017.1312385

By:

Messa, Emanuela;
Biale, Lucia;
Castiglione, Anna;
Lunghi, Monia;
Bonferroni, Margherita;
Salvi, Flavia;
Allione, Bernardino;
Ferrero, Dario;
Calabrese, Chiara;
De Gobbi, Marco;
Nicoli, Paolo;
Gioia, Daniela;
Levis, Alessandro;
Saglio, Giuseppe;
Cilloni, Daniela

Publication type:

Article

Deferasirox has strong anti-leukemia activity but may antagonize theanti-leukemia effect of doxorubicin.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 9, p. 2176, doi. 10.1080/10428194.2017.1280604

By:

Chang, Yu-Chien;
Lo, Wen-Jyi;
Huang, Yu-Ting;
Lin, Chaio-Lin;
Feng, Chiu-Che;
Lin, Hsin-Ting;
Cheng, Hsu-Chen;
Yeh, Su-Peng

Publication type:

Article

Erythroid but not cytogenetic response in a case with 5q− syndrome: a delayed effect of lenalidomide or a consequence of deferasirox treatment?

Published in:

2014

By:

Vigna, Ernesto;
Recchia, Anna Grazia;
Cuzzola, Maria;
Morabito, Lucio;
Gentile, Massimo;
Morabito, Fortunato

Publication type:

Case Study

Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing.

Published in:

Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.065

By:

Jassada Buaboonnam;
Chayamon Takpradit;
Vip Viprakasit;
Nattee Narkbunnam;
Nassawee Vathana;
Kamon Phuakpet;
Kleebsabai Sanpakit;
Bunchoo Pongtanakul

Publication type:

Article

X-ray powder diffraction data for deferasirox, C21H15N3O4.

Published in:

Powder Diffraction, 2016, v. 31, n. 4, p. 298, doi. 10.1017/S0885715616000476

By:

Du, Qiaohong;
Wang, Qing;
Xiong, Xinnuo;
Zeng, Xia;
Li, Hui

Publication type:

Article

Efficacy of Deferasirox as an Oral Iron Chelator in Paediatric Thalassaemia Patients.

Published in:

Journal of Clinical & Diagnostic Research, 2017, v. 11, n. 2, p. 1, doi. 10.7860/JCDR/2017/22650.9395

By:

JAISWAL, SHIKHA;
HISHIKAR, RAJESH;
KHANDWAL, ONKAR;
AGARWAL, MANJU;
JOSHI, USHA;
HALWAI, AJAY;
MAHESHWARI, BASANT;
SHEOHARE, RAKA

Publication type:

Article

Cost-effectiveness Analysis of Deferiprone and Deferasirox on Thalassemia Major Patients in Tangerang District Hospital, Indonesia.

Published in:

Journal of Young Pharmacists, 2018, v. 10, p. s128, doi. 10.5530/jyp.2018.2s.26

By:

Chairunnisa, Hana Ghina;
Sauriasari, Rani;
Rizkyani, Nanda Asyura

Publication type:

Article

Effectiveness and Safety of Deferasirox in Thalassemia with Iron Overload: A Meta-Analysis.

Published in:

Acta Haematologica, 2019, v. 141, n. 1, p. 32, doi. 10.1159/000494487

By:

Dou, Huihong;
Qin, Yuanhan;
Chen, Guoli;
Zhao, Yanjun

Publication type:

Article

Another Step Forward in Iron Chelation Therapy.

Published in:

Acta Haematologica, 2015, v. 134, n. 4, p. 231, doi. 10.1159/000431215

By:

Angelucci, Emanuele

Publication type:

Article

Deferasirox Decreases Liver Iron Concentration in Iron-Overloaded Patients with Myelodysplastic Syndromes, Aplastic Anemia and Other Rare Anemias.

Published in:

Acta Haematologica, 2015, v. 134, n. 4, p. 233, doi. 10.1159/000381893

By:

Kohgo, Yutaka;
Urabe, akio;
Kilinç, Yurdanur;
agaoglu, Leyla;
Warzocha, Krzysztof;
Miyamura, Koichi;
Lim, Lay Cheng;
Glaser, Sabine;
Wang, Candace;
Wiktor-Jedrzejczak, Wieslaw

Publication type:

Article

Improvement in Hematopoiesis after Iron Chelation Therapy with Deferasirox in Patients with Aplastic Anemia.

Published in:

Acta Haematologica, 2013, v. 129, n. 2, p. 72, doi. 10.1159/000342772

By:

Lee, Sung-Eun;
Yahng, Seung-Ah;
Cho, Byung-Sik;
Eom, Ki-Sung;
Kim, Yoo-Jin;
Lee, Seok;
Min, Chang-Ki;
Kim, Hee-Je;
Cho, Seok-Goo;
Kim, Dong-Wook;
Min, Woo-Sung;
Park, Chong-Won;
Lee, Jong Wook

Publication type:

Article

Two-Year Analysis of Efficacy and Safety of Deferasirox Treatment for Transfusional Iron Overload in Sickle Cell Anemia Patients.

Published in:

Acta Haematologica, 2012, v. 128, n. 2, p. 113, doi. 10.1159/000338560

By:

Cancado, Rodolfo;
Olivato, Maria Cristina A.;
Bruniera, Paula;
Szarf, Gilberto;
de Moraes Bastos, Roberto;
Rezende Melo, Murilo;
Chiattone, Carlos

Publication type:

Article

Two-Year Analysis of Efficacy and Safety of Deferasirox Treatment for Transfusional Iron Overload in Sickle Cell Anemia Patients.

Published in:

Acta Haematologica, 2012, v. 128, n. 2, p. 113, doi. 10.1159/000338560

By:

Caneado, Rodolfo;
Olivato, Maria Cristina A.;
Bruniera, Paula;
Szarf, Gilberto;
de Moraes Bastos, Roberto;
Melo, Murilo Rezende;
Chiattone, Carlos

Publication type:

Article

The Oral Iron Chelator Deferasirox Induces Apoptosis in Myeloid Leukemia Cells by Targeting Caspase.

Published in:

Acta Haematologica, 2011, v. 126, n. 4, p. 241, doi. 10.1159/000330608

By:

Kim, Jung-Lim;
Kang, Han-Na;
Kang, Myoung Hee;
Yoo, Young A.;
Kim, Jun Suk;
Choi, Chul Won

Publication type:

Article

A Case of Well-Tolerated and Safe Deferasirox Administration during the First Trimester of a Spontaneous Pregnancy in an Advanced Maternal Age Thalassemic Patient.

Published in:

Acta Haematologica, 2011, v. 125, n. 4, p. 222, doi. 10.1159/000323289

By:

Ricchi, Paolo;
Costantini, Silvia;
Spasiano, Anna;
Di Matola, Tiziana;
Cinque, Patrizia;
Prossomariti, Luciano

Publication type:

Article

Oral Iron Chelator Deferasirox in the Treatment of Secondary Hemochromatosis following Bone Marrow Transplantation in a Patient with Severe Aplastic Anemia.

Published in:

Acta Haematologica, 2011, v. 125, n. 4, p. 219, doi. 10.1159/000322802

By:

Quarta, A.;
Melpignano, A.;
Quarta, G.

Publication type:

Article

A Case of Well-Tolerated and Safe Deferasirox Administration during the First Trimester of a Spontaneous Pregnancy in an Advanced Maternal Age Thalassemic Patient.

Published in:

2011

By:

Ricchi, Paolo;
Costantini, Silvia;
Spasiano, Anna;
Di Matola, Tiziana;
Cinque, Patrizia;
Prossomariti, Luciano

Publication type:

Case Study

HJV Hemochromatosis, Iron Overload, and Hypogonadism in a Brazilian Man: Treatment with Phlebotomy and Deferasirox.

Published in:

Acta Haematologica, 2010, v. 124, n. 4, p. 204, doi. 10.1159/000321493

By:

Santos, Paulo Caleb J. L.;
Cançado, Rodolfo D.;
Pereira, Alexandre C.;
Chiattone, Carlos S.;
Krieger, Jose Eduardo;
Guerra-Shinohara, Elvira M.

Publication type:

Article

Deferasirox Treatment Interruption in a Transfusion-Requiring Myelodysplastic Patient Led to Loss of Erythroid Response.

Published in:

Acta Haematologica, 2010, v. 124, n. 1, p. 46, doi. 10.1159/000314961

By:

Breccia, Massimo;
Loglisci, Giuseppina;
Salaroli, Adriano;
Cannella, Laura;
Santopietro, Michelina;
Alimena, Giuliana

Publication type:

Article

Improved Treatment Satisfaction and Convenience with Deferasirox in Iron-Overloaded Patients with β-Thalassemia: Results from the ESCALATOR Trial.

Published in:

Acta Haematologica, 2010, v. 123, n. 4, p. 220, doi. 10.1159/000313447

By:

Taher, Ali;
Jefri, Abdullah Al;
Elalfy, Mohsen Saleh;
Zir, Kusai Al;
Daar, Shahina;
Rofail, Diana;
Baladi, Jean François;
Habr, Dany;
Kriemler-Krahn, Ulrike;
El-Beshlawy, Amal

Publication type:

Article

Paradoxically Increased Ferritin Level in a Beta-Thalassemia Major Patient following the Start of Deferasirox Chelation Therapy.

Published in:

Acta Haematologica, 2010, v. 123, n. 2, p. 117, doi. 10.1159/000272545

By:

Ricchi, Paolo;
Ammirabile, Massimiliano;
Spasiano, Anna;
Costantini, Silvia;
Cinque, Patrizia;
Matola, Tiziana Di;
Prossomariti, Luciano

Publication type:

Article

Deferasirox (Exjade®) for the Treatment of Iron Overload.

Published in:

Acta Haematologica, 2009, v. 122, n. 2/3, p. 165, doi. 10.1159/000243801

By:

Cappellini, M. D.;
Taher, A.

Publication type:

Article

Eficacia y seguridad de deferasirox en la reducción de ferritina sérica y transaminasas en pacientes con leucemia aguda en remisión que reciben quimioterapia intensiva.

Published in:

Medicina Interna de Mexico, 2014, v. 30, n. 4, p. 393

By:

López-Hernández, Manuel Antonio;
Pérez-Zúñiga, Juan Manuel;
Álvarez-Vera, José Luis;
Alvarado-Ibarra, Martha

Publication type:

Article

Active drug loading and release behaviors of fourfold channel flopped‐ferritin variants.

Published in:

Bulletin of the Korean Chemical Society, 2021, v. 42, n. 12, p. 1666, doi. 10.1002/bkcs.12415

By:

Oh, Hyeok Jin;
Jung, Yongwon

Publication type:

Article